Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gamida Cell Ltd (NQ: GMDA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Gamida Cell Ltd < Previous 1 2 3 Next > Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive April 01, 2024 Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors From Aquestive Therapeutics, Inc. Via GlobeNewswire Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201 October 16, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Issues Update on Israel Operations October 09, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa October 02, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting September 28, 2023 From Gamida Cell Ltd. Via Business Wire First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv) September 27, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference August 31, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update August 14, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Report Second Quarter 2023 Financial Results August 01, 2023 From Gamida Cell Ltd. Via Business Wire Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv) July 11, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference May 31, 2023 From Gamida Cell Ltd. Via Business Wire Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting May 31, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Appoints Terry Coelho as CFO May 22, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update May 15, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast May 11, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces Pricing of $23 Million Public Offering of Securities April 19, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces Launch of Public Offering of Securities April 18, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Stock Jumps Over 100% on FDA Approval April 18, 2023 Gamida Cell Ltd. (NASDAQ: GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight bloo Via MarketBeat Exposures Product Safety Gamida Cell (NASDAQ: GMDA) Announces its Omisirge Allogeneic Cell Therapy Receives FDA Approval April 18, 2023 Gamida Cell Ltd. (NASDAQ: GMDA) is a biopharma company that is focused on utilizing cell therapy to create innovative therapeutics. Via Spotlight Growth Exposures Product Safety Promising Upsides on these Biotech Penny Stocks April 18, 2023 These three biotech stocks each have a consensus Buy rating. While they are down from historic highs, impressive upsides make them worth consideration. Via MarketBeat Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval April 17, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update March 27, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces Changes to Board of Directors March 20, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast March 20, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference March 07, 2023 From Gamida Cell Ltd. Via Business Wire Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR February 18, 2023 From Gamida Cell Ltd. Via Business Wire Gamida Cell Announces Closing of $25 Million Financing With Highbridge December 12, 2022 From Gamida Cell Ltd. Via Business Wire Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences November 23, 2022 From Gamida Cell Ltd. Via Business Wire Gamida Cell Provides Regulatory Update on Omidubicel November 21, 2022 From Gamida Cell Ltd. Via Business Wire Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update November 14, 2022 From Gamida Cell Ltd. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.